As of 2026-03-23, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is 69.56 USD. This relative valuation is based on P/E multiples. With the latest stock price at 74.67 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -6.8%.
The range of the Relative Valuation is 51.57 - 87.21 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 17.7x | 15.2x |
| Forward P/E multiples | 18.9x - 20.2x | 19.9x |
| Fair Price | 51.57 - 87.21 | 69.56 |
| Upside | -30.9% - 16.8% | -6.8% |
| Date | P/E |
| 2026-03-20 | 21.37 |
| 2026-03-19 | 21.41 |
| 2026-03-18 | 21.23 |
| 2026-03-17 | 21.26 |
| 2026-03-16 | 20.66 |
| 2026-03-13 | 20.17 |
| 2026-03-12 | 20.75 |
| 2026-03-11 | 21.83 |
| 2026-03-10 | 21.74 |
| 2026-03-09 | 21.41 |
| 2026-03-06 | 21.19 |
| 2026-03-05 | 21.64 |
| 2026-03-04 | 21.90 |
| 2026-03-03 | 21.78 |
| 2026-03-02 | 21.53 |
| 2026-02-27 | 21.15 |
| 2026-02-26 | 22.08 |
| 2026-02-25 | 21.84 |
| 2026-02-24 | 21.95 |
| 2026-02-23 | 21.49 |
| 2026-02-20 | 22.26 |
| 2026-02-19 | 22.35 |
| 2026-02-18 | 22.27 |
| 2026-02-17 | 22.58 |
| 2026-02-13 | 22.14 |
| 2026-02-12 | 21.95 |
| 2026-02-11 | 21.82 |
| 2026-02-10 | 22.87 |
| 2026-02-09 | 22.99 |
| 2026-02-06 | 23.42 |
| 2026-02-05 | 23.33 |
| 2026-02-04 | 23.26 |
| 2026-02-03 | 22.86 |
| 2026-02-02 | 22.90 |
| 2026-01-30 | 23.43 |
| 2026-01-29 | 23.47 |
| 2026-01-28 | 22.76 |
| 2026-01-27 | 23.02 |
| 2026-01-26 | 23.28 |
| 2026-01-23 | 23.75 |
| 2026-01-22 | 24.44 |
| 2026-01-21 | 24.48 |
| 2026-01-20 | 24.55 |
| 2026-01-16 | 24.28 |
| 2026-01-15 | 24.41 |
| 2026-01-14 | 24.34 |
| 2026-01-13 | 23.55 |
| 2026-01-12 | 24.14 |
| 2026-01-09 | 21.83 |
| 2026-01-08 | 23.19 |